Citadel Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117M | Sell |
246,400
-124,500
| -34% | -$62.7M | 0.02% | 720 |
|
|
2025
Q4 | $173M | Buy |
370,900
+120,700
| +48% | +$56M | 0.03% | 548 |
|
|
2025
Q3 | $107M | Sell |
250,200
-123,500
| -33% | -$47.9M | 0.02% | 806 |
|
|
2025
Q2 | $143M | Buy |
373,700
+93,900
| +34% | +$33.8M | 0.02% | 545 |
|
|
2025
Q1 | $96.7M | Buy |
279,800
+86,900
| +45% | +$27.9M | 0.02% | 718 |
|
|
2024
Q4 | $57.9M | Sell |
192,900
-45,900
| -19% | -$16M | 0.01% | 1154 |
|
|
2024
Q3 | $97.1M | Sell |
238,800
-13,400
| -5% | -$4.91M | 0.02% | 717 |
|
|
2024
Q2 | $81M | Sell |
252,200
-52,700
| -17% | -$17.1M | 0.02% | 806 |
|
|
2024
Q1 | $102M | Sell |
304,900
-10,200
| -3% | -$3.12M | 0.02% | 688 |
|
|
2023
Q4 | $85.3M | Buy |
315,100
+39,200
| +14% | +$9.69M | 0.02% | 783 |
|
|
2023
Q3 | $67.9M | Buy |
275,900
+52,900
| +24% | +$14.5M | 0.01% | 855 |
|
|
2023
Q2 | $67.7M | Sell |
223,000
-105,800
| -32% | -$29.4M | 0.01% | 832 |
|
|
2023
Q1 | $86.7M | Sell |
328,800
-22,500
| -6% | -$5.72M | 0.02% | 700 |
|
|
2022
Q4 | $84.3M | Sell |
351,300
-98,100
| -22% | -$22M | 0.02% | 743 |
|
|
2022
Q3 | $82.6M | Buy |
449,400
+167,200
| +59% | +$33.3M | 0.02% | 712 |
|
|
2022
Q2 | $47.4M | Buy |
282,200
+59,300
| +27% | +$12.7M | 0.01% | 1059 |
|
|
2022
Q1 | $55.9M | Sell |
222,900
-27,400
| -11% | -$6.88M | 0.01% | 1033 |
|
|
2021
Q4 | $64.3M | Sell |
250,300
-3,800
| -1% | -$930K | 0.01% | 972 |
|
|
2021
Q3 | $61.7M | Buy |
254,100
+72,700
| +40% | +$17.8M | 0.01% | 966 |
|
|
2021
Q2 | $37.5M | Buy |
181,400
+3,900
| +2% | +$795K | 0.01% | 1381 |
|
|
2021
Q1 | $33.4M | Sell |
177,500
-62,000
| -26% | -$10.9M | 0.01% | 1416 |
|
|
2020
Q4 | $39.4M | Sell |
239,500
-28,000
| -10% | -$4.09M | 0.01% | 1153 |
|
|
2020
Q3 | $33.4M | Buy |
267,500
+74,900
| +39% | +$9.27M | 0.01% | 1136 |
|
|
2020
Q2 | $18.7M | Sell |
192,600
-49,500
| -20% | -$5.15M | 0.01% | 1562 |
|
|
2020
Q1 | $21.8M | Buy |
242,100
+62,800
| +35% | +$8.13M | 0.01% | 1178 |
|
|
2019
Q4 | $26.5M | Buy |
179,300
+28,300
| +19% | +$3.8M | 0.01% | 1233 |
|
|
2019
Q3 | $18.2M | Sell |
151,000
-36,000
| -19% | -$4.65M | 0.01% | 1568 |
|
|
2019
Q2 | $25.3M | Buy |
187,000
+11,400
| +6% | +$1.44M | 0.01% | 1210 |
|
|
2019
Q1 | $22.9M | Buy |
175,600
+40,500
| +30% | +$5.44M | 0.01% | 1216 |
|
|
2018
Q4 | $16.8M | Buy |
135,100
+17,200
| +15% | +$2.31M | 0.01% | 1375 |
|
|
2018
Q3 | $16.4M | Buy |
117,900
+21,600
| +22% | +$2.69M | 0.01% | 1580 |
|
|
2018
Q2 | $9.88M | Buy |
96,300
+14,200
| +17% | +$1.44M | ﹤0.01% | 1947 |
|
|
2018
Q1 | $7.96M | Sell |
82,100
-62,800
| -43% | -$6.09M | ﹤0.01% | 1946 |
|
|
2017
Q4 | $12.7M | Buy |
144,900
+60,900
| +73% | +$4.89M | 0.01% | 1508 |
|
|
2017
Q3 | $6.69M | Sell |
84,000
-10,200
| -11% | -$820K | 0.01% | 1987 |
|
|
2017
Q2 | $8.21M | Sell |
94,200
-12,200
| -11% | -$1.03M | 0.01% | 1614 |
|
|
2017
Q1 | $9.47M | Sell |
106,400
-81,500
| -43% | -$6.8M | 0.01% | 1489 |
|
|
2016
Q4 | $13.9M | Buy |
187,900
+81,100
| +76% | +$6.07M | 0.01% | 1119 |
|
|
2016
Q3 | $8.08M | Buy |
106,800
+10,300
| +11% | +$789K | 0.01% | 1555 |
|
|
2016
Q2 | $7.43M | Sell |
96,500
-18,600
| -16% | -$1.47M | 0.01% | 1481 |
|
|
2016
Q1 | $8.98M | Buy |
115,100
+12,900
| +13% | +$901K | 0.01% | 1277 |
|
|
2015
Q4 | $6.91M | Sell |
102,200
-14,000
| -12% | -$977K | 0.01% | 1541 |
|
|
2015
Q3 | $8.99M | Sell |
116,200
-124,300
| -52% | -$11M | 0.01% | 1430 |
|
|
2015
Q2 | $21.8M | Buy |
240,500
+90,400
| +60% | +$7.24M | 0.02% | 939 |
|
|
2015
Q1 | $11.3M | Buy |
150,100
+70,500
| +89% | +$5.06M | 0.01% | 1351 |
|
|
2014
Q4 | $5.84M | Sell |
79,600
-5,300
| -6% | -$373K | 0.01% | 1834 |
|
|
2014
Q3 | $5.99M | Buy |
84,900
+29,900
| +54% | +$1.98M | 0.01% | 1825 |
|
|
2014
Q2 | $3.1M | Buy |
55,000
+8,800
| +19% | +$464K | ﹤0.01% | 2297 |
|
|
2014
Q1 | $2.43M | Sell |
46,200
-27,800
| -38% | -$1.38M | ﹤0.01% | 2458 |
|
|
2013
Q4 | $3.53M | Sell |
74,000
-24,000
| -24% | -$1.11M | ﹤0.01% | 1981 |
|
|
2013
Q3 | $4.19M | Sell |
98,000
-15,100
| -13% | -$590K | 0.01% | 1714 |
|
|
2013
Q2 | $4.08M | Buy |
+113,100
| New | +$4.38M | 0.01% | 1755 |
|
Other funds holding HCA
VCM
VPM
Citadel Advisors's HCA Position: Q1 2026 in Review
Citadel Advisors reduced its HCA Healthcare (HCA) stake by 24% in Q1 2026, selling an estimated $41.7M and leaving 258,709 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #690.
Citadel Advisors first reported a position in HCA in Q2 2013 and has held it in 47 quarters since. The position peaked at $317M in Q4 2019. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Citadel Advisors held 258,709 shares of HCA Healthcare worth $122M as of Q1 2026.
- Citadel Advisors sold 82,751 HCA Healthcare shares in Q1 2026, an estimated $41.7M.
- HCA Healthcare made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #690 holding.
- Citadel Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 47 quarters since.
- Citadel Advisors's HCA Healthcare position peaked at $317M in Q4 2019.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.